{"transactions":[{"id":3159354,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-06T22:38:12.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":75000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001387131-20-004497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004497/ownership.xml","form_type":"4"}},{"id":3535052,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T11:15:27.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."}],"balance_after":45000,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001387131-19-003409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003409/ownership.xml","form_type":"4"}},{"id":3895373,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-06-13T21:15:18.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":4.25,"exercise_date":"2019-06-12","expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615774-18-005232","document":"s110812_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005232/s110812_form4.xml","form_type":"4"}},{"id":3903279,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-06T20:05:34.000Z","date":"2018-06-01","kind":"purchase","acquired":true,"shares":7500,"price":3.33,"value":24975.0,"ownership":{"direct":true},"balance_after":23470,"source":{"system":"sec-edgar","filing":"0001615774-18-004909","document":"s110676_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418004909/s110676_form4.xml","form_type":"4"}},{"id":4003222,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T20:31:49.000Z","date":"2016-02-25","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4003221,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T20:31:49.000Z","date":"2017-02-09","kind":"exercise","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4003220,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T20:31:49.000Z","date":"2017-05-27","kind":"exercise","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4003219,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-09T20:31:49.000Z","date":"2016-02-25","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8720,"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4003218,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-09T20:31:49.000Z","date":"2017-02-09","kind":"exercise","acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14845,"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4003217,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-09T20:31:49.000Z","date":"2017-05-27","kind":"exercise","acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15970,"source":{"system":"sec-edgar","filing":"0001615774-18-001748","document":"s109296_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001748/s109296_form4.xml","form_type":"4"}},{"id":4275229,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-21T21:00:41.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":4.18,"exercise_date":"2018-06-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615774-17-003292","document":"s106632_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417003292/s106632_form4.xml","form_type":"4"}},{"id":4571853,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2016-10-31T20:35:46.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Included in the purchase of 100,000 Units at a price of $0.55 per Unit.  Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share."}],"balance_after":25000,"derivative":{"exercise_price":0.63,"exercise_date":"2016-10-31","expiration_date":"2021-10-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001615774-16-007910","document":"s104484_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577416007910/s104484_form4.xml","form_type":"4"}},{"id":4571852,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":149429,"kind":"person","name":"Rhodes John B","position":1,"cik":"0001346251","reported_name":"Rhodes John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-10-31T20:35:46.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Included in the purchase of 100,000 Units at a price of $0.55 per Unit.  Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share."}],"balance_after":137196,"source":{"system":"sec-edgar","filing":"0001615774-16-007910","document":"s104484_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577416007910/s104484_form4.xml","form_type":"4"}}]}